Clinical trials: Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft

Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

• Completed
• Age: 18 to 65 years
• Phase 4
• Results posted

Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

Trial name

MAXIMIZA (NCT01056822)

Testing

1, 2

Where

19 sites in Spain

Volunteers

89 people

Sponsor

Novartis Pharmaceuticals